Get access

Doctor contraceptive-prescribing behaviour and women's attitudes towards contraception: two European surveys

Authors

  • Dominic Grove BA,

    1. Account Manager, Hall & Partners Health, New York, NY, USA
    Search for more papers by this author
  • David J. Hooper MSc

    Corresponding author
    1. Senior Manager, Global Customer Insights, Schering Corp., a Division of Merck & Co., Kenilworth, NJ, USA
      Mr David J. Hooper
      Global Customer Insights
      Schering Corp., a Division of Merck & Co.
      2000 Galloping Hill Road
      Kenilworth NJ 07033-0530
      USA
      E-mail: david.hooper@spcorp.com
    Search for more papers by this author

Mr David J. Hooper
Global Customer Insights
Schering Corp., a Division of Merck & Co.
2000 Galloping Hill Road
Kenilworth NJ 07033-0530
USA
E-mail: david.hooper@spcorp.com

Abstract

Rationale, aims and objectives  Many women are prescribed oestrogen-containing contraceptives for whom oestrogen-containing methods may be less suitable.

Methods  Two surveys examining contraceptive prescription practices among doctors (n = 419) and attitudes towards contraception among women (n = 1623) in France, Germany, Spain, Italy and Russia were evaluated.

Results  Progestin-only pills and hormone-free intrauterine devices were the most commonly prescribed contraceptives for women with medical conditions for which oestrogen-containing methods are not preferred (40% and 20%, respectively), those suffering from oestrogen-related side effects (32% and 21%) and those with concerns about the safety of oestrogen-containing methods (28% and 24%). Combined oral contraceptives (COC) were prescribed to ≥10% in these two groups. One-quarter of contraceptive users had asked to be switched from one COC to another because of oestrogen-related side effects; a similar proportion had been switched by their doctor for this reason. Half of the women surveyed did not want or had concerns about foreign/additional oestrogen, and about 80% said that they would consider switching to a different hormonal contraceptive to minimize oestrogen exposure. Although most doctors were aware of the World Health Organization medical eligibility criteria for contraceptive use, they still prescribed COCs or other oestrogen-containing contraceptives to women with medical conditions for which oestrogen-containing options are not favoured, suggesting a need for additional education.

Conclusion  By complying with guidelines and heeding women's concerns, doctors can individualize their contraceptive recommendation to improve safety, acceptance and compliance and, ultimately, reduce the risk of an unintended pregnancy.

Get access to the full text of this article

Ancillary